# Dyslipidemia Management in Chinese Post Stroke Patients

> **NCT01897883** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 5000 (estimated)

## Conditions studied

- Brain Ischemia,Stoke

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01897883
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2015-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01897883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01897883, "Dyslipidemia Management in Chinese Post Stroke Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01897883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*